Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,287 total articles
Zenas BioPharma has dosed the first subject in a Phase 1 clinical trial for ZB021, a novel oral IL-17AA/AF inhibitor aimed at treating autoimmune diseases such as plaque psoriasis. The trial will assess safety, tolerability, and pharmacokinetics in healthy volunteers, with initial data expected by the end of 2026 and proof-of-concept results in pso…
Eos Energy Enterprises reported a strong first quarter of 2026 with a 445% year-over-year revenue increase to $57 million, achieving record production outputs and improving margins. The company launched Frontier Power USA in partnership with Cerberus, a new independent entity to develop and operate large-scale long-duration energy storage projects,…
Eos Energy Enterprises and Cerberus Capital Management announced the creation of Frontier Power USA, a joint venture focused on building and operating long-duration energy storage projects using Eos's proprietary zinc bromide Z3 technology. Fronted by $100 million equity from Cerberus and a 2 GWh manufacturing capacity reservation, Frontier Power U…
Veru Inc., a U.S.-based late clinical stage biopharmaceutical company, announced its fiscal 2026 Q2 financial results showing reduced losses and increased cash reserves. Simultaneously, the company provided a corporate update highlighting active enrollment in the Phase 2b PLATEAU clinical trial, evaluating enobosarm plus semaglutide for obesity man…
Aprea Therapeutics announced its first quarter 2026 financial results and corporate update, including progress in its Phase 1 trial ACESOT-1051 for APR-1051, a WEE1 inhibitor, with two partial responses observed and favorable tolerability. The company closed an oversubscribed $30 million private placement to bolster its cash position, now at $46.5 …
Global-e Online Ltd. reported robust Q1 2026 financial results with Gross Merchandise Value (GMV) growing 40% year-over-year to $1.742 billion, revenues up 33% to $252.1 million, and Adjusted EBITDA more than 50% higher to $50.2 million, reflecting strong operational leverage. The company expanded its merchant base across multiple international reg…
Voyager Therapeutics announced positive three-month GLP toxicology data for VY1706, their investigational tau silencing gene therapy for Alzheimer’s disease, showing good tolerability and significant tau protein reduction in non-human primates. The company expects to submit an IND application in Q2 2026 and initiate clinical trials in the second ha…
Costamare Bulkers Holdings Limited announced their financial results for the first quarter ended March 31, 2026, highlighting net income of $9.9 million and adjusted net income of $12.4 million. The company strengthened liquidity with $353.3 million in cash and undrawn credit, and ended Q1 with cash exceeding debt by $127.2 million. Key strategic m…
Zenas BioPharma detailed significant progress in Q1 2026, including upcoming FDA and EMA submissions for obexelimab treating IgG4-RD, completion of enrollment in SLE and Phase 1 trials, ongoing Phase 3 trials for orelabrutinib in MS, and a strengthened balance sheet with cash runway into 2029. The company projects multiple clinical and regulatory m…
Zymeworks Inc., a biotech company specializing in novel biotherapeutics for difficult diseases, announced management's participation in several upcoming investor conferences including the 2026 Stifel Virtual Targeted Oncology Forum, TD Cowen Oncology Innovation Summit, and Jefferies Global Healthcare Conference. The company highlighted its portfoli…
TransUnion's latest fraud trends report reveals that Canadians faced a higher rate of suspected digital fraud attempts in 2025 compared to the global average, with 13% of Canadians reporting monetary losses, averaging CAD$1,301. The highest fraud risk occurs at account login stages, primarily involving stolen credit card fraud and third-party selle…
Titan Mining Corporation has entered into a cooperation agreement with Teck Resources to evaluate the recovery of germanium from existing processing waste streams at its Empire State Mine. This initiative could unlock a new revenue stream by extracting germanium, a critical mineral for defense and semiconductor sectors, without additional mining. T…
Atour Lifestyle Holdings Limited (NASDAQ: ATAT), a leading Chinese lifestyle group, announced a cash dividend of US$0.18 per ordinary share (US$0.54 per ADS) as the first dividend payment in 2026 under its three-year annual dividend policy adopted in August 2024. The total dividend distribution amounts to approximately US$72 million, reflecting the…
Atour Lifestyle Holdings Limited (NASDAQ: ATAT) announced robust unaudited financial results for Q1 2026, reporting a 47.5% year-over-year increase in net revenues and a 90.3% increase in net income. The company expanded its hotel network by 20.9% year-over-year, operating 2,088 hotels with over 232,000 rooms. Growth was driven by manachised hotels…
Equinox Gold Corp. and Orla Mining Ltd. have entered into a definitive agreement for an at-market merger to create North America's new senior gold producer, combining six mines across Canada, U.S., Mexico, and Nicaragua. The merged entity anticipates 1.1 million ounces of gold production in 2026, anchored by three long-life Canadian mines and a sig…
WeRide Inc., a Nasdaq-listed autonomous driving technology company, reported a 58% year-over-year revenue increase to US$16.5 million in Q1 2026 driven by growth in robotaxi and L4 vehicle sales. The company expanded its global robotaxi fleet to approximately 1,300 vehicles, launched new services in Singapore and Dubai, and advanced L2++ ADAS comme…
GEN Restaurant Group, Inc. announced it has received its first direct purchase order from Costco's Southern California regional team, securing freezer aisle placement for its ready-to-cook marinated meat products in approximately 40 Costco locations across Southern California and Hawaii. This direct order bypassed the traditional regional roadshow …
BlackRock Asset Management Canada Limited, a subsidiary of BlackRock, Inc., announced the May 2026 cash distributions for multiple iShares ETFs traded on the Toronto Stock Exchange and Cboe Canada. Distributions will be paid to unitholders on various dates in May and June, with detailed per-unit amounts listed for a wide range of funds, covering bo…
Aurora Mobile Limited (NASDAQ: JG), a leading provider of customer engagement and marketing technology services, announced it will release its unaudited financial results for Q1 ended March 31, 2026, on May 26, 2026, before U.S. markets open. The company will host an earnings conference call on the same day to discuss the results.
Qfin Holdings, a leading AI-powered Credit-Tech platform in China, announced it will report its unaudited financial results for Q1 ended March 31, 2026, after U.S. market close on May 26, 2026. The company will also host a conference call to discuss the results and business progress.
UCLOUDLINK GROUP INC. announced its Q1 2026 financial results showing a 10.1% decrease in revenues to $16.9 million compared to the prior year. While total data consumption and user metrics grew, the company posted a net loss of $3.5 million, larger than last year's $0.6 million loss, primarily due to significant marketing and expansion investments…
PMGC Holdings Inc. (Nasdaq: ELAB) has acquired A&B Aerospace, Inc., a precision machining and aerospace manufacturing company specializing in high-tolerance parts for aerospace and defense markets. The acquisition advances PMGC's roll-up strategy to build a U.S.-based precision manufacturing platform serving aerospace, defense, and industrial clien…
Willis Towers Watson (NASDAQ: WTW) has introduced a fully integrated Carbon Capture and Storage (CCS) insurance suite designed to support developers and operators across the CO2 capture, transportation, and storage value chain. The solution offers end-to-end risk coverage, liability protection, and financial safeguards aligned with regulatory and c…
Aligos Therapeutics, a clinical-stage biopharmaceutical company, announced that ten scientific abstracts detailing their innovative therapies for chronic hepatitis B virus and metabolic liver diseases have been accepted for presentation at the prestigious 2026 EASL Congress. These presentations underscore Aligos' expanding pipeline and commitment t…
Assembly Biosciences announced it will present topline Phase 1a data of ABI-6250, its investigational oral hepatitis D virus entry inhibitor, at the EASL Congress 2026. The data support advancing ABI-6250 directly into Phase 2 studies by year-end. ABI-6250 is the only oral entry inhibitor in development for chronic hepatitis D and aims to address a…
